ShardaCare Healthcity with GIFT to host thalassaemia awareness with a free HLA testing camp: Our Bureau, Bengaluru Tuesday, January 13, 2026, 12:45 Hrs [IST] ShardaCare Healthcity ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...
A preliminary 46% prevalence of the HLA-A*02 allele in screened patients supports the company's sample size estimates, reinforcing confidence in the trial's validity. Expansion of the non-HLA-A*02 arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback